{
  "group_ancestors": {
    "group2": "group1",
    "group3": "group1",
    "group4": "group2",
    "group5": "group2",
    "group6": "group2",
    "group7": "group2",
    "group8": "group2",
    "group9": ["group4", "group5", "group3"]
  },
  "data_elements": [
    {
      "id": "i1",
      "type": "icon",
      "data": {
        "group": "group1",
        "popover": {
          "header": "research",
          "body": "Developing an artificially intelligent referral system to fulfill the informational needs of women diagnosed with breast cancer."
        }
      },
      "position": { "x": 140, "y": 210 }
    },
    {
      "id": "i2",
      "type": "icon",
      "data": {
        "group": "group1",
        "popover": {
          "header": "research",
          "title": "RUBY - Expanded Genetic Testing in Women with Young Onset Breast Cancer",
          "link": "https://spherecalgary.ca/abstract-ruby"
        }
      },
      "position": { "x": 320, "y": 365 }
    },
    {
      "id": "1",
      "type": "custom",
      "data": {
        "group": "group1",
        "labels": ["Patient diagnosed with", "new breast cancer"],
        "popover": {
          "header": "Patient diagnosed with new breast cancer",
          "body": "Risk of underlying genetic mutation:<br/>Increased - younger age at breast cancer diagnosis, strong family history of breast or associated cancers, triple negative breast cancer diagnosis, higher grade breast cancer."
        }
      },
      "position": { "x": -20, "y": 250 }
    },
    {
      "id": "e1-3",
      "arrowHeadType": "arrow",
      "source": "1",
      "target": "3",
      "type": "custom",
      "data": { "group": "group1" }
    },
    {
      "id": "2",
      "type": "custom",
      "data": {
        "group": "group1",
        "labels": ["Patient presents to", "high risk clinic"],
        "popover": {
          "header": "Patient presents to high risk clinic",
          "body": "Patient factors:<br/> Increased breast cancer risk - previous mantle radiotherapy to chest wall, family history of breast cancer or associated cancer, known genetic mutation predisposing to breast cancer, previous LCIS.<br/><br/>Decreased breast cancer risk - age menopause < 45, bilateral saplingo-oophorectomy < 40 years, no family history of breast or associated cancers."
        }
      },
      "position": { "x": 0, "y": 500 }
    },
    {
      "id": "e2-3",
      "source": "2",
      "target": "3",
      "type": "custom",
      "data": { "group": "group1" }
    },
    {
      "id": "3",
      "type": "custom",
      "data": {
        "group": "group1",
        "labels": ["Risk assessment"]
      },
      "position": { "x": 200, "y": 400 }
    },
    {
      "id": "e3-4",
      "source": "3",
      "target": "4",
      "type": "custom",
      "data": { "group": "group1" }
    },
    {
      "id": "4",
      "type": "custom",
      "data": {
        "group": "group1",
        "labels": ["Patient, family history &", "breast disease factors"]
      },
      "position": { "x": 370, "y": 389 }
    },
    { "id": "e4-5", "source": "4", "target": "5", "type": "custom", "data": { "group": "group2" } },
    {
      "id": "5",
      "type": "custom",
      "data": {
        "group": "group2",
        "labels": ["High risk"],
        "popover": {
          "header": "High risk",
          "body": "Lifetime risk of new breast cancer diagnosis >30%"
        }
      },
      "position": { "x": 600, "y": 250 }
    },
    { "id": "e5-7", "source": "5", "target": "7", "type": "custom", "data": { "group": "group2" } },
    {
      "id": "7",
      "type": "custom",
      "data": {
        "group": "group2",
        "labels": ["Discuss following options", "with medical oncologist", "and/ or breast surgeon"]
      },
      "position": { "x": 740, "y": 228 }
    },
    { "id": "e4-6", "source": "4", "target": "6", "type": "custom", "data": { "group": "group3" } },
    {
      "id": "6",
      "type": "custom",
      "data": {
        "group": "group3",
        "labels": ["Average risk"],
        "popover": {
          "header": "Average risk",
          "body": "Lifetime risk of new breast cancer diagnosis <17%"
        }
      },
      "position": { "x": 600, "y": 600 }
    },
    { "id": "e6-8", "source": "6", "target": "8", "type": "custom", "data": { "group": "group3" } },
    {
      "id": "8",
      "type": "custom",
      "data": {
        "group": "group3",
        "labels": ["Breast aware"],
        "popover": {
          "header": "Breast aware",
          "body": "Regular self-examination same time each menstrual cycle"
        }
      },
      "position": { "x": 1000, "y": 600 }
    },
    { "id": "e7-9", "source": "7", "target": "9", "type": "custom", "data": { "group": "group4" } },
    {
      "id": "9",
      "type": "custom",
      "data": {
        "group": "group4",
        "labels": ["Breast aware"],
        "popover": {
          "header": "Breast aware",
          "body": "Regular self-examination same time each menstrual cycle"
        }
      },
      "position": { "x": 1000, "y": 140 }
    },

    { "id": "e7-10", "source": "7", "target": "10", "type": "custom", "data": { "group": "group5" } },
    {
      "id": "10",
      "type": "custom",
      "data": {
        "group": "group5",
        "labels": ["Imaging", "surveillance"],
        "popover": {
          "header": "Imaging surveillance",
          "body": "Annual breast MRI from age 30 (TP53 mutation carriers - from age 20) up to minimum age 40.<br/><br/>Annual Mammogram from age 40 for a minimum of ten years until qualify for National Screening Programme (excluding TP53 mutation carriers)."
        }
      },
      "position": { "x": 1000, "y": 220 },
      "targetPosition": "left",
      "sourcePosition": "right"
    },

    { "id": "e7-11", "source": "7", "target": "11", "type": "custom", "data": { "group": "group6" } },
    {
      "id": "11",
      "type": "custom",
      "data": {
        "group": "group6",
        "labels": ["Chemoprevention"],
        "popover": {
          "header": "Chemoprevention",
          "body": "Discuss risks and benefits of maximum 5 years hormone therapy (tamoxifen) which may reduce hormone sensitive breast cancer risk by up to 50% for those at high risk of breast cancer. Side-effect profile of this must be discussed prior to commencing."
        }
      },
      "position": { "x": 1000, "y": 320 }
    },

    {
      "id": "e7-12",
      "source": "7",
      "target": "12",
      "type": "custom",
      "data": { "group": "group7" }
    },
    {
      "id": "12",
      "type": "custom",
      "data": {
        "group": "group7",
        "labels": ["Risk reduction", "surgery"],
        "popover": {
          "header": "Risk reduction surgery",
          "body": "Discussion with your breast and plastics surgeon the options of risk reduction surgery with or without reconstruction.<br/><br/>This is a long process that requires careful work up, including a minimum of two appointments with your operating surgeon, an appointment with a clinical psychochologist as well as approval from the entire breast surgery multi-disciplinary team."
        }
      },
      "position": { "x": 1000, "y": 400 },
      "targetPosition": "left",
      "sourcePosition": "right"
    },

    { "id": "p1-e7-13", "source": "7", "target": "13", "type": "custom", "data": { "group": "group8" } },
    {
      "id": "13",
      "type": "custom",
      "data": {
        "group": "group8",
        "labels": ["Genetic testing"],
        "popover": {
          "header": "Genetic testing",
          "body": "Genetic counselling will be offered with no obligation, but the option, to undergo genetic testing on completion of this, should the patient wish it. This is not required to proceed to the next tabs."
        }
      },
      "position": { "x": 1000, "y": 500 },
      "targetPosition": "left",
      "sourcePosition": "right"
    },
    { "id": "e8-14", "source": "8", "target": "14", "arrowHeadType": "arrow", "type": "custom" },
    {
      "id": "e9-14",
      "source": "9",
      "target": "14",
      "arrowHeadType": "arrow",
      "type": "custom",
      "data": { "group": "group4" }
    },
    {
      "id": "e10-14",
      "source": "10",
      "target": "14",
      "arrowHeadType": "arrow",
      "type": "custom",
      "data": { "group": "group5" }
    },
    {
      "id": "14",
      "type": "custom",
      "data": {
        "group": "group9",
        "labels": ["New breast change/", "abnormal imaging"]
      },
      "position": { "x": 1200, "y": 400 }
    },
    {
      "id": "e14-15",
      "source": "14",
      "target": "15",
      "arrowHeadType": "arrow",
      "type": "custom",
      "data": { "group": "group9" }
    },
    {
      "id": "15",
      "type": "custom",
      "data": {
        "group": "group9",
        "labels": ["Go to", "'Clinical Assessment'"],
        "style": { "background": "linear-gradient(70deg, #66CCE7 1%, #91edab 99% )", "color": "#000000" },
        "onClickGoTo": 1
      },
      "position": { "x": 1400, "y": 400 },
      "targetPosition": "left",
      "sourcePosition": "right"
    }
  ]
}
